Siponimod

Overview

Siponimod is a selective S1P1 and S1P5 agonist with EC50 of 0.39 nM and 0.98 nM, respectively. It has been approved by US FDA for the treatment of patients with active secondary progressive multiple sclerosis (SPMS).

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Neurological Disease | Sphingosine-1-phosphate receptor 1(S1PR1)

Product Information

• Catalog No.: B0084-463380
• CAS No.: 1230487-00-9
• Molecular Formula: C29H35F3N2O3
• Molecular Weight: 516.6
• Purity: >98%

Source

Original product source